Immunological and pathological evaluation of rhesus macaques infected with Leishmania major

Experimental Parasitology

Volumn 103, Issue 3-4, 2003, Pages 160-168

  Freidag, Brenda L ^a   Mendez, Susana ^a   Cheever, Allen W ^b   Kenney, Richard T ^c   Flynn, Barbara ^a   Sacks, David L ^a   Seder, Robert A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c IOMAI Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; IMMUNOLOGICAL PARAMETERS; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PRIORITY JOURNAL; PROMASTIGOTE; PROTOZOAL INFECTION; RHESUS MONKEY; SPECIES COMPARISON;

ANIMALIA; LEISHMANIA MAJOR; MACACA; MACACA MULATTA; PRIMATES; PROTOZOA;

EID: 0043172504     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4894(03)00099-7     Document Type: Article

References (19)

1. Amaral V.F., Teva A., Porrozzi R., Silva A.J., Pereira M.S., Oliveira-Neto M.P., Grimaldi G.J. Jr. Leishmania major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous re-infections. Memorias do Instituto Oswaldo Cruz. 96:2001;795-804.
2. Amaral V.F., Ransatto V.A., Conceicao-Silva F., Molinaro E., Ferreira V., Coutinho S.G., McMahon-Pratt D., Grimaldi G.J. Jr. Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. Experimental Parasitology. 82:1996;34-44.
3. Campos-Neto A., Porrozzi R., Greeson K., Coler R.N., Webb J.R., Seiky Y.A., Reed S.G., Grimaldi G.J. Jr. Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infection and Immunity. 69:2001;4103-4108.
4. Castes, M., Blackwell, J., Trujillo, D., Formica, S., Cabrera, M., Zorrilla, G., Rodas, A., Castellanos, P.L., Convit, J., 1994. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I. Skin-test reactivity, T-cell proliferation and interferon-γ
5. Coutinho S.G., Da-Cruz A.M., Bertho A.L., Santiago M.A., De Luca P. Immunologic patterns associated with cure in human American cutaneous leishmaniasis. Brazilian Journal of Medical and Biological Research. 31:1998;139-142.
6. Gicheru M.M., Olobo J.O., Anjili C.O., Orago A.S., Modabber F., Scott P. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infection and Immunity. 69:2001;245-251.
7. Githure J.I., Reid G.D., Binhazim A.A., Anjili C.O., Shatry A.M., Hendricks L.D. Leishmania major: the suitability of East African nonhuman primates as animal models for cutaneous leishmaniasis. Experimental Parasitology. 64:1987;438-447.
8. Gurunathan S., Prussin C., Sacks D.L., Seder R.A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Medicine. 4:1998;1409-1415.
9. Gurunathan S., Sacks D.L., Brown D.R., Reiner S.L., Charest H., Glaichenhaus N., Seder R.A. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. Journal of Experimental Medicine. 186:1997;1137-1147.
10. + T cells. Journal of Immunology. 165:2000;915-924.
11. Kemp M., Hey A.S., Kurtzhals J.A., Christensen C.B., Gaafar A., Mustafa M.D., Kordofani A.A., Ismail A., Kharazmi A., Theander T.G. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clinical and Experimental Immunology. 96:1994;410-415.
12. Kenney R.T., Sacks D.L., Sypek J.P., Vilela L., Gam A.A., Evans-Davis K. Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis. Journal of Immunology. 163:1999;4481-4488.
13. Kumar, A., Weiss, W., Tine, J.A., Hoffman, S.L., Rogers, W.O., 2001. ELIspot assay for detection of peptide specific interferon-γ
14. Mendez S., Gurunathan S., Kamhawi S., Belkaid Y., Moga M.A., Skeiky Y.A., Campos-Neto A., Reed S., Seder R.A., Sacks D. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. Journal of Immunology. 166:2001;5122-5128.
15. Nadim A., Javadian E., Tahvildar-Bidruni G., Ghorbani M. Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales. 76:1983;377-383.
16. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceicao-Silva F., Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigation. 91:1993;1390-1395.
17. + T cell responses and protection against Leishmania major infection. Journal of Experimental Medicine. 195:2002;1565-1573.
18. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annual Review of Immunology. 13:1995;151-177.
19. Verthelyi D., Kenney R.T., Seder R.A., Gam A.A., Friedag B., Klinman D.M. CpG oligodeoxynucleotides as vaccine adjuvants in primates. Journal of Immunology. 168:2002;1659-1663.